← Leaderboards
Ivaylo B Mihaylov
Rhode Island Hospital
$1,547,906
Attributed
$1,547,906
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $318.5K · FY2012–17$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,547,906 · 1
By mechanism
R01$1,547,906 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMethodologyAffectMalignant Neoplasm Of ProstateBaseClinical TrialsCohortCancer PatientCancer TherapyData CollectionClinical PracticeDoseEquipmentEvaluationFaceGenerationsHead And Neck Squamous Cell CarcinomaComputer FrameworkCostInnovationIntensity-Modulated RadiotherapyInterestDensityModality
Grant awards (6)
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$318,513
R01 · FY2017 · CA · contact PI
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$318,513
R01 · FY2016 · CA · contact PI
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$308,958
R01 · FY2015 · CA · contact PI
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$1
R01 · FY2014 · CA · contact PI
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$299,321
R01 · FY2013 · CA · contact PI
Improving Cancer Treatment Planning by DMH-Based Inverse Optimization$302,600
R01 · FY2012 · CA · contact PI